Global Hormone replacement therapy Market Analysis, Drivers, Restraints, Opportunities, Trends, and Growth Forecast to 2027
MarketResearch.biz, in its upcoming report titled, “Global Hormone Replacement Therapy Market Trends, Applications, Analysis, Growth, and Forecast to 2027”, offers in-depth insights, revenue details, and other vital information regarding the global hormone replacement therapy market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report also offers insightful and detailed information regarding the various key players operating in the global hormone replacement therapy market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global hormone replacement therapy has been segmented on the basis of hormonal therapy, route of administration, and region.
On the basis of hormonal therapy, the global market is segmented into estrogen replacement therapy, growth hormone replacement therapy, thyroid replacement therapy, and others. Hormone replacement therapy is a mode of replacing hormones when an individual’s body is naturally unable to produce hormones at a specific time. Hormonal deficiency occurs in women at a particular age, or at the time of menopause (typically between the ages of 45 to 55 years), as well as in patients suffering from dwarfism due to high hormone deficiency. Currently, a mixture of drugs is being used for treating hormone deficiencies in order to have better efficacy and safety parameter. Simultaneously, hormone replacement therapy involves a certain amount of risk and has an adverse effect that can causes breast cancer, cervical cancer, uterine cancer, and bowel cancer.
Major factors driving demand for hormone replacement therapies include increasing awareness regarding post-menopausal hazards, rising demand in other therapeutic areas such as growth hormone therapy and thyroid hormone therapy, novel formulation strategies, increasing anti-aging therapy, and rising unmet medical requirements globally. New formulations of drugs such as transdermal drugs, gels and creams which can be easily accessible in the market has a major contribution towards growth of the hormone replacement therapy market. In addition to this, reduction in risk incidence of osteoporosis, cardiovascular disease, and vasomotor symptom are also expected to boost the hormone replacement therapy market years ahead.
Few Side effects in hormone replacement therapy that obstruct the popularity in therapeutic area are fluid retention, headache, indigestion, and depression. Besides these, chances of blood clots can emerge due to regular intake of HRT (Hormone Replacement Therapy) drugs, and at the same time these restraints are being ignored when compared with other benefits of HRT. Aging coupled with rising disposable income level are vital factors that are gearing up the market revenue growth. Availability of drugs in varied strengths, dosage forms are the major factors that boost up the revenue growth in the market
Furthermore, on the basis of region, North America dominated the market. While the market in the APAC region is expected to grow during the forecast period.
Global Hormon replacement therapy Market Segmentation:
Global hormone replacement therapy market segmentation by product:
Global hormone replacement therapy market segmentation by route administration:
- Oral tablets
- Transdermal patches
Global hormone replacement therapy market segmentation by disease:
- Male hypogonadism
- Growth hormone deficiency
Global hormone replacement therapy market segmentation by distribution:
- Hospital pharmacies
- Retail pharmacies and drugstores
- Compounding pharmacies
Global hormone replacement therapy market segmentation by region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Bayer Pharma AG
- Abbott Laboratories
- AbbVie, Inc.
- Allergan plc
- Orion Pharma AB
- Novo Nordisk A/S
- Mylan Laboratories
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!